Septerna (SEPN) Equity Average (2023 - 2026)
Septerna's quarterly Equity Average came in at $380.2 million in Q1 2026, up 3744.01% year-on-year from $9.9 million in Q1 2025, and down 1.33% quarter-over-quarter from $385.3 million in Q4 2025.
Septerna has reported Equity Average for 4 years, with the latest figure at $380.2 million in Q1 2026.
- For the quarter ending Q1 2026, Equity Average rose 3744.01% year-over-year to $380.2 million; the trailing twelve-month figure through Mar 2026 stood at $380.2 million (up 3744.01% YoY), and the FY2025 full-year result was $401.0 million, up 110.12% from the prior year.
- Equity Average for Q1 2026 stood at $380.2 million, down from $385.3 million in the prior quarter.
- The five-year high for Equity Average was $385.3 million in Q4 2025, with the low at -$77.6 million in Q3 2024.
- Average Equity Average over 4 years is $107.5 million, with a median of -$732000.0 recorded in 2025.
- Year-over-year, Equity Average jumped 81.02% in 2025 and jumped 3744.01% in 2026.
- Tracing SEPN's Equity Average over 4 years: stood at -$56.1 million in 2023, then surged by 396.41% to $166.3 million in 2024, then jumped by 131.68% to $385.3 million in 2025, then retreated by 1.33% to $380.2 million in 2026.
- The last three Equity Average figures came in at $380.2 million (Q1 2026), $385.3 million (Q4 2025), and $383.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.76 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 21.35 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.01 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.34 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 932.28 Mn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | 380.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 380.19 Mn |
| Dec 31, 2025 | 385.33 Mn |
| Sep 30, 2025 | 383.14 Mn |
| Jun 30, 2025 | -11.35 Mn |
| Mar 31, 2025 | 9.89 Mn |
| Dec 31, 2024 | 166.32 Mn |
| Sep 30, 2024 | -77.59 Mn |
| Jun 30, 2024 | -59.83 Mn |
| Mar 31, 2024 | -45.13 Mn |
| Dec 31, 2023 | -56.11 Mn |